ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 116 filers reported holding ENZO BIOCHEM INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,000 | -72.2% | 1,315 | -81.0% | 0.00% | – |
| Q4 2020 | $18,000 | +350.0% | 6,932 | +236.0% | 0.00% | – |
| Q3 2020 | $4,000 | -90.7% | 2,063 | -87.1% | 0.00% | – |
| Q2 2020 | $43,000 | +38.7% | 15,972 | +17.2% | 0.00% | – |
| Q1 2020 | $31,000 | +106.7% | 13,627 | +138.1% | 0.00% | – |
| Q4 2019 | $15,000 | +7.1% | 5,723 | +47.8% | 0.00% | – |
| Q3 2019 | $14,000 | +7.7% | 3,871 | +3.5% | 0.00% | – |
| Q2 2019 | $13,000 | +550.0% | 3,739 | +502.1% | 0.00% | – |
| Q4 2018 | $2,000 | +100.0% | 621 | +104.3% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 304 | -2.9% | 0.00% | – |
| Q2 2018 | $2,000 | -98.1% | 313 | -97.5% | 0.00% | – |
| Q4 2017 | $104,000 | -22.4% | 12,738 | 0.0% | 0.00% | – |
| Q3 2017 | $134,000 | -32.3% | 12,738 | -28.8% | 0.00% | – |
| Q2 2017 | $198,000 | +32.0% | 17,890 | 0.0% | 0.00% | – |
| Q1 2017 | $150,000 | +23.0% | 17,890 | 0.0% | 0.00% | – |
| Q4 2016 | $122,000 | +2340.0% | 17,890 | +633.2% | 0.00% | – |
| Q2 2013 | $5,000 | – | 2,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |